Recent Press Releases

Medidata and Japan Pharmaceutical Manufacturers Association Collaborate on New Research Aimed at Streamlining Clinical Trial Costs Across Japan

NEW YORK--()--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced a research collaboration with the Japan...

Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials

DAVIS, Calif. -- Mytrus, a technology and services company revolutionizing clinical trials, announced today that its software platform for electronic informed consent has received approval for use by...

PPD Collaborates with CISYS LifeSciences to Implement New Web-based Event Adjudication System

WILMINGTON, N.C. & RALEIGH, N.C.--()--Pharmaceutical Product Development, LLC (PPD) and CISYS LifeSciences today announced PPD's implementation of Sequence WebEAS, a new...

WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device...

Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc.

OKLAHOMA CITY, OK--(Marketwired) - Cytovance® Biologics, Inc., announced today that they have entered into a definitive agreement by which Hepalink USA Inc. will acquire Cytovance® Biologics...

AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients

ALBANY, N.Y. -- AMRI (NASDAQ: AMRI) and Saneca Pharmaceuticals, a.s. today announced a strategic collaboration focused on the development, manufacture and marketing of a portfolio of opium-derived...

PAREXEL Names Maykin Ho to Board of Directors

BOSTON, Aug. 26, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of Directors have elected...

TxCell Consortium Granted €1.28 million for TRUST Project on Process and Clinical Development of Col-Treg for Autoimmune Uveitis Treatment

French Government and local authorities award grant from the Unique Interministerial Fund (FUI) to the consortium composed of TxCell, Provepep, Hospital La Pitié Salpêtrière...

INC Research Enhances Therapeutic Expertise with Key Promotions in General Medicine and CNS

Industry leaders to drive innovation across key clinical research areas RALEIGH, N.C., Aug. 25, 2015 – INC Research Holdings, Inc. (Nasdaq: INCR), a leading, global Phase I to IV contract...

WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm

SHANGHAI, Aug. 25, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. WX, -1.02% a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology,...

Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection

Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection 26 August 2015: Recipharm AB, Stockholm, today announces that it has signed an...

Accutest Expands Into Latin American Countries to Support Drug Development

MUMBAI, August 24, 2015 /PRNewswire/ -- Accutest Research Laboratories, a leading global Contract Research Organization (CRO), further pursues its strategic expansion into Latin America by opening...

INC Research Announces Pricing of Secondary Offering

RALEIGH, N.C. -- INC Research Holdings, Inc. (INCR), a leading global Phase I to Phase IV contract research organization, announced the pricing of its secondary offering of 8,000,000 shares of its...

Accelovance, Inc. to Expand Global Workforce with Grant from Welsh Government

ROCKVILLE, Md. -- Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in Oncology, Vaccines, and General Medicine clinical development is expanding its...

WuXi PharmaTech and TruTag Technologies Complete Successful Testing of Edible On-Dose Authentication Solution for Pharmaceuticals

SHANGHAI and HONOLULU -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical...

Chiltern Announces Agreement to Acquire Theorem Clinical Research

LONDON & WILMINGTON, N.C.--Chiltern, a leading global contract research organization (CRO), announced it has signed a purchase agreement to acquire Theorem Clinical Research, another leading...

iCardiac Acquires Clinical Trials Division of nSpire Health

iCardiac Acquires Clinical Trials Division of nSpire Health Transaction Adds Respiratory and ePRO Services to Its Leading Cardiac Safety Offering August 6, 2015 Rochester, NY – iCardiac...

Flexion Therapeutics Expands Supply Capacity for FX006 by Entering Into Agreement With Patheon

- Adding Patheon as a contract manufacturer, in addition to Evonik Corporation, bolsters manufacturing capacity for planned commercialization of company's lead program BURLINGTON, Mass. --...

Quintiles Announces Closing of Secondary Public Offering

RESEARCH TRIANGLE PARK, N.C. – Quintiles Transnational Holdings Inc. ("Quintiles") (NYSE: Q) announced today the closing of an underwritten, secondary public offering of 7,000,000...

ICON Forms Partnership with Mereo BioPharma for Clinical Development

ICON is sole provider of clinical development services Dublin, Ireland – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical,...